- Research works
- 2 ▼ 34% vs 2013–17
- Citations
- 54 22.8 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 51% world 28%
Not ranked overall: Chungang Industry (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Chungang Industry (South Korea) publish most on?
By volume in 2022–2025: Protein Degradation and Inhibitors, Histone Deacetylase Inhibitors Research and Multiple Myeloma Research and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Protein Degradation and Inhibitors Molecular Biology 0 works
- 2 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
- 3 Multiple Myeloma Research and Treatments Hematology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Chungang Industry (South Korea)'s research output changed?
Output in 2018–2022 was 34% lower than in 2013–2017.
Other research institutions in Incheon
- Inha University
- Incheon National University
- Gachon University Gil Medical Center
- Inha University Hospital
- National Institute of Environmental Research
- Korea Polar Research Institute
- The Catholic University of Korea Incheon St. Mary's Hospital
- National Institute of Biological Resources
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.